Dachaigh › Cancer Ovarian › Illinois › Chicago
Sgrùdaidhean clionaigeach Cancer Ovarian ann an Chicago, IL
Tha 36 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann agus timcheall air Chicago (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- Research Site, Chicago
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
A’ fastadhÌre 2/3
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A’ fastadhÌre 2
- Mount Sinai Hospital Medical Center, Chicago
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- agus 3 a bharrachd
A Study of PHST001 in Advanced Solid Tumors
A’ fastadhÌre 1
- University of Chicago Medical Center, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A’ fastadhÌre 1
- University of Chicago Hospital, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 2
- University of Illinois Cancer Center, Chicago
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
A’ fastadhÌre 1
- University of Chicago Medical Center /ID# 278295, Chicago
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
A’ fastadhSgrùdadh amharc
- University of Chicago, Chicago
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A’ fastadhÌre 2
- Rush Md Anderson Cancer Center /ID# 274926, Chicago
- University of Chicago Medical Center /ID# 274796, Chicago
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
A’ fastadhÌre 1/2
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago Medical Center, Chicago
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A’ fastadhÌre 3
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- The University of Chicago Medicine, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A’ fastadhÌre 1
- Northwestern University Feinberg School of Medicine, Chicago
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A’ fastadhÌre 3
- The University of Chicago Medicine, Chicago
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
A’ fastadhÌre 2
- University of Chicago, Chicago
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A’ fastadhÌre 1
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
A’ fastadhÌre 2
- University of Chicago, Chicago
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
A’ fastadhÌre 1
- University of Chicago Medical Center, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
A’ fastadhÌre 1/2
- Lurie Children's Hospital-Chicago, Chicago
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
A’ fastadh
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
- agus 2 a bharrachd
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A’ fastadhÌre 3
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- agus 1 a bharrachd
A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
A’ fastadhÌre 1
- Rush University Medical Center, Chicago
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
A’ fastadhÌre 2
- The University of Chicago Medical Center, Chicago
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
A’ fastadhÌre 2
- Northwestern Memorial Hospital, Chicago
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A’ fastadhÌre 1
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- University of Chicago Medical Center, Chicago
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
A’ fastadhÌre 1/2
- Northwestern University, Chicago
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
A’ fastadhÌre 1/2
- Northwestern Memorial Hospital, Chicago
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
A’ fastadh
- Northwestern University, Chicago
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
A’ fastadhÌre 1/2
- University of Chicago Medical Center, Chicago
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
A’ fastadh
- UChicago Medicine, Chicago
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- University of Chicago Medical Center, Chicago
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
A’ fastadh
- Northwestern Memorial Hospital, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A’ fastadhÌre 1
- The University of Chicago Comprehensive Cancer Center, Chicago
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
A’ fastadhÌre 2
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Chicago
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
A’ fastadhÌre 2
- Northwestern University, Chicago
Sgrùdaidhean Cancer Ovarian ann am bailtean eile
- Houston, TX89 sgrùdaidhean
- New York City, NY69 sgrùdaidhean
- Boston, MA61 sgrùdaidhean
- Los Angeles, CA50 sgrùdaidhean
- Nashville, TN49 sgrùdaidhean
- Arlington, VA46 sgrùdaidhean
- Philadelphia, PA44 sgrùdaidhean
- Columbus, OH39 sgrùdaidhean
- St. Louis, MO38 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Cleveland, OH30 sgrùdaidhean
- Pittsburgh, PA30 sgrùdaidhean
Sgrùdaidhean eile ann an Chicago
- Aillse Sgamhain Neo-chealla-beag61 sgrùdaidhean
- Aillse a' bhroilleach59 sgrùdaidhean
- Aillse (gach seòrsa)51 sgrùdaidhean
- Ailse metastatach45 sgrùdaidhean
- Aillse Prostata45 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Obesity41 sgrùdaidhean
- Aillse colorectal34 sgrùdaidhean
- Buailteach34 sgrùdaidhean
- Fàilligeadh a' Chridhe31 sgrùdaidhean
- Ro-throm29 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.